Type II DNA topoisomerases are ubiquitous enzymes that catalyze the ATP-dependent transport of one segment of duplex DNA through an enzyme-mediated transient break in a second DNA duplex (1-4). These enzymes participate in many DNA metabolic pathways, including the segregation of newly replicated DNA molecules (5, 6) and the condensation of chromosomes in mitosis and meiosis (7, 8) . They are also the targets of a diverse group of antibiotics and anticancer agents (9, 10).
Type II DNA topoisomerases from organisms as diverse as bacteriophages, prokaryotes, and eukaryotes are structurally and mechanistically related (11, 12 (13, 14) . However, the rate of ATP hydrolysis is stimulated 20-fold by DNA, the DNA cleavage/religation equilibrium is perturbed by the presence of ATP and, most importantly, the passage of one DNA through a transient break in another only occurs in the presence of ATP (15, 16) . When the topoisomerase binds ATP, it undergoes a major conformational change such that the enzyme topologically clamps down around DNA (17) . By studying a preparation of topoisomerase II in which one subunit was immunotagged and defective in ATP binding and the other was wild type, it was shown that ATP binding to one protomer can induce a concerted conformational change in the entire enzyme (18) .
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Two general mechanisms, often termed the "one-gate" and "two-gate" models, have been proposed for the functioning of topoisomerase II (3, (19) (20) (21) (22) Ala-Arg-Gly-Tyr-Pro-Tyr-Asp-Val-Pro-Asp-Tyr-Ala for topoII(C->A)Ha, and Ala-Arg-Gly-Gly-Gly-Arg-Met-Lys-GlnLeu-Glu-Asp-Lys-Val-Glu-Glu-Leu-Leu-Ser-Lys-Asn-Tyr-HisLeu-Glu-Asn-Glu-Val-Ala-Arg-Leu-Lys-Lys-Leu-Val-Gly-GluAbbreviations: G segment, gated segment; T segment, transported segment.
Arg-Gly-Gly-Cys for topoII(C->A)zipGGC; the boldface letters represent the amino acids making up the Ha epitope and the GCN4 leucine zipper, respectively. Expression, Purification, and Oxidative Cross-Linking of Proteins. The vectors pJEL203 and pJEL205 were transformed into the protease-deficient yeast strain BCY123 (27) and expressed as described (24) . Using these expression conditions, <1% of the topoisomerase II purified comes from the chromosomal copy of the wild-type TOP2 gene; the remainder of protein is from the plasmid-borne gene (16, 27) . The topoisomerase derivatives were purified as described (24) Although the carboxyl-terminal disulfide bond provides the covalent attachment between the two protomers of topoII(C-> A)zipGGC, the leucine zipper may also provide significant intradimeric stability (26) . Therefore, instead of only comparing the reduced and oxidized forms of topoII(C-*A)zipGGC, a second chimeric protein, topoII(C-*A)Ha, was used as a control protein (see Fig. 1A ). In this protein the leucine zipper and carboxylterminal cysteine are replaced by the 10-amino acid Ha epitope.
The Cross-Link Forms Efficiently and Intradimerically. As shown in Fig. 1B , topoII(C-A)zipGGC can be efficiently cross-linked upon oxidation. TopoII(C->A)Ha (lanes 1 and 2) or topoII(C->A)zipGGC (lanes 3 and 4) were treated with 1 mM diamide and incubated as described (Fig. 1 legend) dimers under denaturing conditions. However, only intradimerically disulfide-bonded topoII(C->A)zipGGC will have approximately the same native molecular weight as an uncrosslinked topoisomerase dimer. By contrast, interdimerically cross-linked topoII(C--A)zipGGC will have at least twice the native molecular weight. These possibilities can be distinguished by determining the relative sedimentation coefficients of oxidized topoII(C--A)zipGGC and topoII(C-+A)Ha. Analysis of fractions collected from a glycerol gradient containing a mixture of these proteins is shown in Fig. 2 . The immunoblot shown in Fig. 2A was probed with anti-Ha antibodies to show the fractions containing the uncross-linked topoII(C->A)Ha. The blot in Fig. 2B was probed with polyclonal antitopoisomerase II antibodies and therefore shows the fractions containing both the cross-linked and uncross-linked proteins. These blots clearly show that both the cross-linked and uncross-linked proteins are in exactly the same fractions.
To show that these sedimentation conditions are capable of separating a topoisomerase dimer from a twice-larger protein, an identical gradient run simultaneously was loaded with a mixture of thyroglobulin (native molecular mass of 660 kDa) and topoII(C-,A)Ha. The peak fractions containing thyroglobulin and topoII(C--A)Ha from this gradient are indicated in Fig. 2 by "th" and "to," respectively. These sedimentation conditions were clearly sufficient for separating large proteins whose native molecular weights differ by a factor of two. In addition, a similar mixture of topoII(C--A)zipGGC and topoII(C->A)Ha was analyzed on a Superdex 200 gel filtration column; again, the two proteins eluted in identical fractions (data not shown). Taken together, these data show that the leucine zipper and disulfide bond of topoII(C->A)zipGGC formed intradimerically. (16) . Approximately the same is found for the cysteineless fusion proteins (Fig. 3) .
The results of the supercoil relaxation assay are shown in Fig. 3 . The same proteins that were analyzed by SDS/PAGE in Fig. lb were used for this assay; the assays of uncross-linked topoII(C-A)Ha are in a and comparable assays for the cross-linked protein are in b. Three different concentrations of enzyme were compared, and in each case there was no significant difference in activity seen between the uncrosslinked and cross-linked enzymes. The first lane for each reaction time course (labeled "0") shows the results of incubating a reaction aliquot in the absence of ATP for 10 min. The ATP dependence of the reactions shows that type II DNA topoisomerase activity is being measured, and not contaminating topoisomerase I activity. Additionally, topoisomerase II mutants known to be inactive have been expressed, purified, and shown to have no activity in the same assay (16) .
To further insure that the cross-linked enzyme is an active type II DNA topoisomerase, it was also assayed for its ability to decatenate interlinked kinetoplast DNA circles. A comparison of the decatenation activities of topoII(C->A)Ha, topoII(C->A)zipGGC (oxidized), and topoII(C->A)zipGGC (reduced) is shown in Fig. 4 . Again, there is no significant difference in activity detected between the enzymes. Indeed, there is certainly not the 10-fold difference in activity expected were only the small fraction of nondisulfide-bonded topoII(C--A)zipGGC responsible for all of the activity. (17) .
In model a, a potential "one-gate" model, the T segment is the first DNA to bind in the enzyme cleft, followed by binding and cleavage of the G segment (i). Upon binding ATP, the enzyme undergoes a conformational change that simultaneously drives the T segment through the gate in the G segment and dimerizes the amino termini of the enzyme (ii). Upon ATP hydrolysis, the amino termini again separate, allowing the religated G segment either to dissociate or become the T segment for a second round of reaction (iii). One observation that is potentially inconsistent with this model is that the first DNA to bind to the topoisomerase is the cleaved DNA (17) . However (35, 36) , study homo-versus heterodimerization (37) , and analyze sequence requirements for coiled-coil formation in vivo (38) . Site-specific incorporation of cysteines was used in many studies to produce covalent cross-links between polypeptides by oxidative disulfide bond formation (see ref. 39 ) for a representative example). This work reports combining these two approaches to specifically and covalently crosslink the two protomers of a dimeric fusion protein together. Besides mechanistic studies, this cross-linked topoisomeraseleucine zipper fusion protein may also be useful in creating and stabilizing heterodimeric enzymes in which one protomer is wild type and the other is mutant; such heterodimers are very useful for studies of allostery (18) . In addition, this tethered enzyme may help solve the question of whether low levels of illegitimate DNA recombination postulated to be catalyzed by topoisomerase II occurs by a subunit exchange mechanism (40) .
The topoisomerase II derivatives used in this paper do not have any of the nine naturally occurring cysteines. There was no previous indication that any of the cysteines would be required for catalysis; nevertheless, experiments presented here provide direct evidence that DNA topoisomerase II does not require any cysteines for its catalytic activity.
